| 000 | 01883 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518012206.0 | ||
| 264 | 0 | _c20190522 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0208028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRudenko, Larisa | |
| 245 | 0 | 0 |
_aRationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model. _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0208028 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aCross Protection _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFerrets |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _xgenetics |
| 650 | 0 | 4 |
_aInfluenza A Virus, H3N2 Subtype _xgenetics |
| 650 | 0 | 4 |
_aInfluenza B virus _xgenetics |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xblood |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 650 | 0 | 4 |
_aVaccines, Attenuated _xadministration & dosage |
| 700 | 1 | _aKiseleva, Irina | |
| 700 | 1 | _aKrutikova, Elena | |
| 700 | 1 | _aStepanova, Ekaterina | |
| 700 | 1 | _aRekstin, Andrey | |
| 700 | 1 | _aDonina, Svetlana | |
| 700 | 1 | _aPisareva, Maria | |
| 700 | 1 | _aGrigorieva, Elena | |
| 700 | 1 | _aKryshen, Kirill | |
| 700 | 1 | _aMuzhikyan, Arman | |
| 700 | 1 | _aMakarova, Marina | |
| 700 | 1 | _aSparrow, Erin Grace | |
| 700 | 1 | _aTorelli, Guido | |
| 700 | 1 | _aKieny, Marie-Paule | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 12 _gp. e0208028 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0208028 _zAvailable from publisher's website |
| 999 |
_c29121793 _d29121793 |
||